Dr Reddys Laboratories Quarterly Results for Trading Insights
DRREDDY • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,337 Cr
QSept 2025
Dr Reddys Laboratories Quarterly Results Key Highlights
- Revenue of ₹9,135 Cr in Sept 2025 (+1.1% vs Mar 2025, +9.7% vs Sept 2024)
- Net Profit of ₹1,337 Cr in Sept 2025 (-15.8% vs Mar 2025, -0.4% vs Sept 2024)
- EBITDA of ₹2,317 Cr in Sept 2025 (-7.4% vs Mar 2025)
- Operating Margin of 23.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹16.18 in Sept 2025 (-15.4% vs Mar 2025)
Dr Reddys Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 9,135 | 9,034 | 8,836 | 8,330 | 7,284 | 1.1% | 9.7% |
| Net Profit (₹ Cr) | 1,337 | 1,587 | 1,410 | 1,342 | 1,310 | - | - |
| EBITDA (₹ Cr) | 2,317 | 2,503 | 2,437 | 2,368 | 2,001 | - | - |
| EPS (₹) | 16.18 | 19.12 | 17.04 | 75.40 | 78.66 | - | - |
| Operating Margin (%) | 23.0% | 23.0% | 25.0% | 26.0% | 25.0% | - | - |
Dr Reddys Laboratories Share Price Trend Around Quarterly Results
Visualize Dr Reddys Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Dr Reddys Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Dr Reddys Laboratories
Additional stock information and data for DRREDDY
Revenue Trend (₹ Cr)
Sept 2024
8,330
Jun 2025
8,836
Mar 2025
9,034
Sept 2025
9,135
Net Profit Trend (₹ Cr)
Sept 2024
1,342
Jun 2025
1,410
Mar 2025
1,587
Sept 2025
1,337
Operating Margin Trend (%)
Sept 2024
26.0%
Jun 2025
25.0%
Mar 2025
23.0%
Sept 2025
23.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Dr Reddys Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Lupin
Sept 2025 |
₹100,719.57 Cr | 2149.7 | 6,921 | 1,485 | +23.2% | - | 21.5% | 66.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores